Shares of Moderna Inc.
shed 0.10% to $159.87 Thursday, on what proved to be an all-around favorable buying and selling session for the inventory market, with the NASDAQ Composite Index
rising 1.31% to 14,038.76 and the Dow Jones Industrial Common
rising 0.90% to 34,035.99. The inventory’s fall snapped a two-day profitable streak. Moderna Inc. closed $29.39 beneath its 52-week excessive ($189.26), which the corporate reached on February eighth.
The inventory underperformed when in comparison with a few of its rivals Thursday, as AbbVie Inc.
rose 0.93% to $106.89, Amgen Inc.
rose 2.21% to $255.13, and AstraZeneca PLC ADR
rose 1.99% to $50.83. Buying and selling quantity (10.3 M) eclipsed its 50-day common quantity of 8.8 M.